Intra-articular hydrogel formulation prolongs the in vivo stability of Toll-like receptor antagonistic peptides for rheumatoid arthritis treatment
- J. Control. Release Jun 26 2024, 372 S0168-3659(24)00383-3 | https://doi.org/10.1016/j.jconrel.2024.06.034